News & Analysis on Clinical Trial Services & Contract Research And Development
Isotag and Biocode merge to form Authentix, specialising in technologies used in the prevention of counterfeiting, adulteration and diversion of products. Pharmaceuticals will be a key focus of the combined entity.
Cambrex has appointed a new CEO to oversee the combination of its small-molecule and biological active pharmaceutical ingredient (API) activities into a single business unit.
Funding shortfalls and a capacity gap are threatening to hamper the European biopharmaceutical industry's progress and could lead to a reduction in its global market share, according to new market research.